儿童癌症的免疫微环境特征
该研究通过基因表达和免疫组化分析五种儿童癌症(尤文肉瘤、骨肉瘤、横纹肌肉瘤、髓母细胞瘤、神经母细胞瘤各20例,共100份样本)的免疫微环境并与总生存期关联。结果显示神经母细胞瘤和横纹肌肉瘤免疫细胞基因表达高但抗原加工细胞基因低,骨肉瘤和尤文肉瘤T细胞低但抗原加工细胞基因最高,髓母细胞瘤呈免疫荒漠,多数肿瘤PD-L1阴性。肿瘤浸润CD8 T细胞越低,神经母细胞瘤、横纹肌肉瘤和尤文肉瘤预后越好。
要点
- 神经母细胞瘤和横纹肌肉瘤免疫细胞基因表达及T细胞计数高,但抗原加工细胞基因低。
- 骨肉瘤和尤文肉瘤T细胞水平低,但抗原加工细胞基因水平最高;骨肉瘤巨噬细胞标志物水平最高,尤文肉瘤最低。
- 100份样本中仅11份PD-L1染色阳性,PD-L1和OX40水平在五种肿瘤中普遍较低。
核心结论
- 研究描述了五种主要儿童癌症免疫细胞的数量和质量,并提供了区分这些肿瘤与成人肿瘤类型的关键特征。
- 这些发现解释了抗PD-(L)1单药在儿童癌症中可能未获成功的原因。
- 结果为儿童复发/难治性癌症的生物学分层和个体化免疫治疗策略开发提供了依据。
研究设计与样本
- 通过基因表达和免疫组化(IHC)研究五种主要儿童癌症的免疫微环境:尤文肉瘤(ES)、骨肉瘤(OS)、横纹肌肉瘤(RMS)、髓母细胞瘤(MB)和神经母细胞瘤(NB),每种20例,共100份样本。
- 将免疫微环境特征与总生存期进行关联分析。
主要发现
- NB和RMS肿瘤免疫细胞基因表达值高、T细胞计数高,但抗原加工细胞(APC)基因低。
- OS和ES肿瘤T细胞水平低,但APC基因水平最高;OS巨噬细胞标志物(CSF1R、CD163和CD68)水平最高,ES最低。
- MB表现为免疫荒漠;RMS和OS中Tregs(FOXP3染色)较高。
- 100份样本中仅11份PD-L1染色阳性,PD-L1和OX40水平在五种肿瘤中普遍较低。
- NB中CD8的IHC水平与基因表达水平与成人肿瘤相当,但基因表达显示T细胞毒性分子GZMB、GZMA和PRF1水平低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical development of immune checkpoint-targeted immunotherapies has been disappointing so far in paediatric solid tumours. However, as opposed to adults, very little is known about the immune contexture of paediatric malignancies. METHODS: We investigated by gene expression and immunohistochemistry (IHC) the immune microenvironment of five major paediatric cancers: Ewing sarcoma (ES), osteosarcoma (OS), rhabdomyosarcoma (RMS), medulloblastoma (MB) and neuroblastoma (NB; 20 cases each; n = 100 samples total), and correlated them with overall survival. RESULTS: NB and RMS tumours had high immune cell gene expression values and high T-cell counts but were low for antigen processing cell (APC) genes. OS and ES tumours showed low levels of T-cells but the highest levels of APC genes. OS had the highest levels of macrophages (CSF1R, CD163 and CD68), whereas ES had the lowest. MB appeared as immune deserts. Tregs (FOXP3 staining) were higher in both RMS and OS. Most tumours scored negative for PD-L1 in tumour and immune cells, with only 11 of 100 samples positive for PD-L1 staining. PD-L1 and OX40 levels were generally low across all five indications. Interestingly, NB had comparable levels of CD8 by IHC and by gene expression to adult tumours. However, by gene expression, these tumours were low for T-cell cytotoxic molecules GZMB, GZMA and PRF1. Surprisingly, the lower the level of tumour infiltrative CD8 T-cells, the better the prognosis was in NB, RMS and ES. Gene expression analyses showed that MYCN-amplified NB have higher amounts of immune suppressive cells such as macrophages, myeloid-derived suppressor cells and Tregs, whereas the non-MYCN-amplified tumours were more infiltrated and had higher expression levels of Teff. CONCLUSIONS: Our results describe the quality and quantity of immune cells across five major paediatric cancers and provide some key features differentiating these tumours from adult tumour types. These findings explain why anti-PD(L)1 might not have had single agent success in paediatric cancers. These results provides the rationale for the development of biologically stratified and personalised immunotherapy strategies in children with relapsing/refractory cancers.
引用
- Thakur MD, Franz CJ, Brennan L, et al. Immune contexture of paediatric cancers. Eur J Cancer. 2022. PMID: 35660252. doi:10.1016/j.ejca.2022.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。